Integrated Management of Type 2 Diabetes Mellitus and Depression Treatment to Improve Medication Adherence: A Randomized Controlled Trial

PURPOSE Depression commonly accompanies diabetes, resulting in reduced adherence to medications and increased risk for morbidity and mortality. The objective of this study was to examine whether a simple, brief integrated approach to depression and type 2 diabetes mellitus (type 2 diabetes) treatment improved adherence to oral hypoglycemic agents and antidepressant medications, glycemic control, and depression among primary care patients. METHODS We undertook a randomized controlled trial conducted from April 2010 through April 2011 of 180 patients prescribed pharmacotherapy for type 2 diabetes and depression in primary care. Patients were randomly assigned to an integrated care intervention or usual care. Integrated care managers collaborated with physicians to offer education and guideline-based treatment recommendations and to monitor adherence and clinical status. Adherence was assessed using the Medication Event Monitoring System (MEMS). We used glycated hemoglobin (HbA1c) assays to measure glycemic control and the 9-item Patient Health Questionnaire (PHQ-9) to assess depression. RESULTS Intervention and usual care groups did not differ statistically on baseline measures. Patients who received the intervention were more likely to achieve HbA1c levels of less than 7% (intervention 60.9% vs usual care 35.7%; P <.001) and remission of depression (PHQ-9 score of less than 5: intervention 58.7% vs usual care 30.7%; P <.001) in comparison with patients in the usual care group at 12 weeks. CONCLUSIONS A randomized controlled trial of a simple, brief intervention integrating treatment of type 2 diabetes and depression was successful in improving outcomes in primary care. An integrated approach to depression and type 2 diabetes treatment may facilitate its deployment in real-world practices with competing demands for limited resources.

[1]  M. Olfson,et al.  Continuity of antidepressant treatment for adults with depression in the United States. , 2006, The American journal of psychiatry.

[2]  M. Folstein,et al.  Population-based norms for the Mini-Mental State Examination by age and educational level. , 1993, JAMA.

[3]  M. Fowler.  Clinical Practice Recommendations , 2009, Clinical Diabetes.

[4]  M. Harris,et al.  Racial and ethnic differences in health care access and health outcomes for adults with type 2 diabetes. , 2001, Diabetes care.

[5]  C. Lyketsos,et al.  Examining a bidirectional association between depressive symptoms and diabetes. , 2008, JAMA.

[6]  M. Moridani,et al.  Analytical evaluation of hemoglobin A(1c) dual kit assay on Bio-Rad Variant II: an automated HPLC hemoglobin analyzer for the management of diabetic patients. , 2003, Clinical biochemistry.

[7]  H. Bogner,et al.  Integrating Type 2 Diabetes Mellitus and Depression Treatment Among African Americans , 2010, The Diabetes educator.

[8]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[9]  M. Dimatteo,et al.  Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. , 2000, Archives of internal medicine.

[10]  W. Katon,et al.  Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. , 2000, Archives of internal medicine.

[11]  Justin Feigelman,et al.  Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis , 2010, The Lancet.

[12]  F. Petrak,et al.  Treatment of depression in diabetes: an update , 2009, Current opinion in psychiatry.

[13]  M. Fowler,et al.  Clinical Practice Recommendations , 2009, Clinical Diabetes.

[14]  J. Mundt,et al.  Effectiveness of antidepressant pharmacotherapy: The impact of medication compliance and patient education , 2001, Depression and anxiety.

[15]  F. Camacho,et al.  Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. , 2003, Clinical therapeutics.

[16]  W. Assendelft,et al.  Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. , 2001, Diabetes care.

[17]  H. Bogner,et al.  Integration of Depression and Hypertension Treatment: A Pilot, Randomized Controlled Trial , 2008, The Annals of Family Medicine.

[18]  Evette Ludman,et al.  The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. , 2004, Archives of general psychiatry.

[19]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[20]  C. Spreeuwenberg,et al.  Integrated care: meaning, logic, applications, and implications – a discussion paper , 2002, International journal of integrated care.

[21]  A. Karter,et al.  Disparities in HbA1c Levels Between African-American and Non-Hispanic White Adults With Diabetes , 2006, Diabetes Care.

[22]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[23]  F. Pouwer,et al.  Depression and Quality of Life in Patients with Diabetes: A Systematic Review from the European Depression in Diabetes (EDID) Research Consortium , 2009, Current diabetes reviews.

[24]  D. M. Smith.  Toward Common Ground , 1997, Diabetes Care.

[25]  M. Carnethon,et al.  Symptoms of depression as a risk factor for incident diabetes: findings from the National Health and Nutrition Examination Epidemiologic Follow-up Study, 1971-1992. , 2003, American journal of epidemiology.

[26]  Wendy Macdonald,et al.  Identifying Psychosocial Interventions That Improve Both Physical and Mental Health in Patients With Diabetes , 2010, Diabetes Care.

[27]  Michael C. Dreiling,et al.  Comparison of Laboratory Test Frequency and Test Results Between African-Americans and Caucasians With Diabetes: Opportunity for Improvement: Findings from a large urban health maintenance organization , 1997, Diabetes Care.

[28]  Do Peterson,et al.  Collaborative care for patients with depression and chronic illnesses. , 2010, The New England journal of medicine.

[29]  J. Angst.  Clinical Course of Affective Disorders , 1988 .

[30]  H. Wittchen,et al.  Diabetes in Primary Care: Prospective Associations between Depression, Nonadherence and Glycemic Control , 2010, Psychotherapy and Psychosomatics.

[31]  J. Leeman.  Interventions to Improve Diabetes Self-management , 2006, The Diabetes educator.

[32]  L. Rubenstein,et al.  The Acceptability of Treatment for Depression Among African-American, Hispanic, and White Primary Care Patients , 2003, Medical care.

[33]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[34]  Carolyn Rutter,et al.  Cost-effectiveness of systematic depression treatment among people with diabetes mellitus. , 2007, Archives of general psychiatry.

[35]  R. Spitzer,et al.  The PHQ-9: validity of a brief depression severity measure. , 2001, Journal of general internal medicine.

[36]  F. Pouwer,et al.  Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis , 2010, Diabetologia.

[37]  R C Peveler,et al.  Compliance with tricyclic antidepressants: the value of four different methods of assessment. , 2000, British journal of clinical pharmacology.

[38]  A. Dietrich,et al.  Systematic review of multifaceted interventions to improve depression care. , 2007, General hospital psychiatry.

[39]  M. Mimiaga,et al.  Depression and Diabetes Treatment Nonadherence: A Meta-Analysis , 2008, Diabetes Care.

[40]  A. Stewart,et al.  The MOS short-form general health survey. Reliability and validity in a patient population. , 1988, Medical care.

[41]  A. Beekman,et al.  Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis , 2006, Diabetologia.

[42]  H. Bogner,et al.  Diabetes, Depression, and Death: A Randomized Controlled Trial of a Depression Treatment Program for Older Adults Based in Primary Care (PROSPECT) , 2008, Diabetes Care.

[43]  R. Clouse,et al.  Depression in diabetic patients: the relationship between mood and glycemic control. , 2005, Journal of diabetes and its complications.

[44]  K. Farmer,et al.  Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. , 1999, Clinical therapeutics.

[45]  F. Pouwer,et al.  Depressive symptoms are associated with physical inactivity in patients with type 2 diabetes. The DIAZOB Primary Care Diabetes study. , 2009, Family practice.

[46]  K. Humphreys,et al.  Depression Increases Diabetes Symptoms by Complicating Patients’ Self-Care Adherence , 2004, The Diabetes educator.

[47]  W. Katon,et al.  Potentially Modifiable Factors Associated With Disability Among People With Diabetes , 2005, Psychosomatic medicine.